Plain language review: non-invasive screening for metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) in primary care.
What is this summary about?Metabolic dysfunction–associated steatotic liver disease, or MASLD, and its severe form, metabolic dysfunction–associated steatohepatitis, or MASH, impose significant global burdens on patients and healthcare systems. It is important to identify people with MASLD and MASH, as these conditio...